Log In
Print
BCIQ
Print
Print this Print this
 

Rhopressa (AR-13324)

  Manage Alerts
Collapse Summary General Information
Company Aerie Pharmaceuticals Inc.
DescriptionDual inhibitor of Rho kinase and the norepinephrine transporter
Molecular Target Rho kinase ; Norepinephrine transporter
Mechanism of ActionRho kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today